Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jasmine Stamps
Institution:
aTyr Pharma (United States)
Observed institution:
aTyr Pharma (United States)
ORCID:
0000-0003-4515-7290
Observed ORCID:
0000-0003-4515-7290
OpenAlex ID:
A5073792511
Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis
2026
·
Ryan A. Adams
, Ying-Ting Wang
, et al.
·
Journal of Biological Chemistry
Abstract 1758: Resistance to cancer therapy via upregulation of the NRP2/VEGF-C axis can be neutralized by ATYR2810
2023
·
Alison Barber
, Zhiwen Xu
, et al.
·
Cancer Research
Abstract LB085: ATYR2810, a fully humanized monoclonal antibody targeting the VEGF-NRP2 pathway sensitizes highly aggressive and chemoresistant TNBC subtypes to chemotherapy
2022
·
Zhiwen Xu
, Alison Barber
, et al.
·
Cancer Research
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type
